Engraftment and molecular monitoring of CD34+ peripheral-blood stem- cell transplants for follicular lymphoma: A pilot study

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2288-2295

  McQuaker, I G ^a   Haynes, A P ^a   Anderson, S ^a   Stainer, C ^a   Owen, R G ^a   Morgan, G J ^a   Lumley, M ^a   Milligan, D ^a   Fletcher, J ^a   Bessell, E M ^a   Davis, J M ^a   Russell, N H ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL MOTILITY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030978024     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2288     Document Type: Article

References (34)

1. Horning S, Rosenberg SA: The natural history of initially untreated non-Hodgkin's lymphomas. N Engl J Med 311:1471-1475, 1984
2. Ersboll J, Schultz HB, Pederson-Bjergaard J, et al: Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumour progression. Eur J Haematol 42:155-163, 1989
3. Soubeyran P, Eghbali H, Bonichon F, et al: Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients. Eur J Cancer 27:1606-1613, 1991
4. Morel P, Dupriz B, Plantier-Colcher I, et al: Long-term outcome of follicular low-grade lymphoma. A report of 91 patients. Ann Hematol 66:303-308, 1993
5. Hubbard SM, Chabner BA, De Vita VT Jr, et al: Histologic progression of non-Hodgkin's lymphoma. Blood 59:258-264, 1982
6. Acker B, Hoppe RT, Colby TV, et al: Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1:11-16, 1983
7. Schouten HC, Bierman PJ, Vaughan WP, et al: Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histological transformation. Blood 74:2579-2584, 1989
8. Johnson PWM, Rohatiner AZS, Whelan JS, et al: Patterns of survival in patients with recurrent follicular lymphoma: A 20 year study from a single center. J Clin Oncol 13:140-147, 1995
9. Freedman AS, Ritz J, Neuberg D, et al: Autologous bone marrow transplantation in 69 patients with a history of low-grade non-Hodgkin's lymphoma. Blood 77:2524-2529, 1991
10. Rohatiner AZS, Johnson PWM, Price CGA, et al: Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177-1184, 1994
11. Colombat P, Donadio D, Fouillard L, et al: Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 13:157-162, 1994
12. Foucar K, McKenna RW, Frizzera G, et al: Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Blood 54:1417-1422, 1979
13. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 47:19-28, 1986
14. Weiss LM, Warnke RA, Sklar J, et al: Molecular analysis of the t(14; 18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987
15. Dolken G, Illerhaus G, Hirt C, et al: bcl-2/J(h) rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333-1344, 1996
16. Limpens J, Stad R, Vos C, et al: Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85:2528-2536, 1995
17. Gribben JG, Saporito L, Barber M, et al: Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detecable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083-1089, 1992
18. Haas R, Moos M, Karcher A, et al: Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol 12:1685-1692, 1994
19. Freedman AS, Gribben JG, Neuberg D, et al: High-dose therapy and autologous bone-marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780-2786, 1996
20. To LB, Moore S, Juttner CA: Residual leukemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukemia. Leukemia Res 11:327-329, 1987
21. Craig JIO, Langlands K, Parker AC, et al: Molecular detection of tumor contamination of peripheral blood stem cell harvests. Exp Hematol 22:898-902, 1994
22. Bird JM, Bloxham D, Samson D, et al: Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 88:110-116, 1994
23. Bastion Y, Brice P, Haioun C, et al: Intensive therapy with peripheral-blood progenitor-cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257-3262, 1995
24. Berenson RJ, Bensinger WI, Kalamasz D, et al: Engraftment of dogs with la-positive marrow-cells isolated by avidin biotin immunoadsorption. Blood 69:1363-1367, 1987
25. + marrow-cells engraft lethally irradiated baboons. J Clin Invest 81:951-955, 1988
26. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717-1722, 1991
27. Shpall EJ, Jones RB, Bearman SI, et al: Transplantation of enriched CD34 positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD 34 positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36, 1994
28. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390-397, 1995
29. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647-1654, 1995
30. Dyer MJS, Fischer P, Nacheva E, et al: A new human B-cell non-Hodgkin's lymphoma cell (Karpas 422) exhibiting both t(14; 18) and t(4; 11) chromosomal translocation. Blood 75:709-714, 1990
31. Gribben JG, Freedman AS, Neuberg D, et al: Immunological purging of marrow assessed by PCR before autlogous marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991
32. Sharp JG, Kessinger A, Mann S, et al: Outcome of high-dose therapy and autologous transplantation in non-Hodgkins-lymphoma based the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol 14:214-219, 1996
33. + progenitors in bone marrow of Bcl2-IgH positive follicular lymphoma patients. Blood 86:4691-4698, 1995
34. + cells with a different antigenic profile compared with use during steady state hematopoiesis. Bone Marrow Transplant 14:827-832, 1994